ISPOR 19TH ANNUAL EUROPEAN CONGRESS EXPLORES EUROPEAN COOPERATION IN HEALTH TECHNOLOGY ASSESSMENT

Published Oct 31, 2016
Vienna, Austria—31 October 2016—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR)  facilitated a discussion on National Health Technology Assessment (HTA) Process and European Cooperation on HTA: Fit for Purpose? this morning at the Society’s 19th Annual European Congress in Vienna, Austria.  The panel was moderated by Finn Børlum Kristensen, MD, PhD, Professor, University of Southern Denmark, Hilleroed, Denmark. Speakers for the discussion panel included:
  • Dominik Schnichels, Head of Unit, DG SANTE B4, Medical Products: Quality, Safety, Innovation, European Commission, Brussels, Belgium
  • Zoe Garrett, MRes, Senior Technical Adviser, Centre for Health Technology Evaluation, National Institute for Health and Care Excellence, Manchester, UK
  • Rui Santos Ivo, Vice-President, Executive Board, National Authority of Medicines and Health Products, Lisbon, Portugal
  • Tomas Tesar, PharmD, PhD, MBA, Member, Reimbursement Committee, Union Health Insurance Fund, Bratislava, Slovakia
The panelists acknowledged that while decision making on patient access to health technologies will remain a sole national competence of the European Union (EU) Member States, they stressed that opportunities do exist to improve European cooperation on HTA. Through the work of EUnetHTA, European cooperation on HTA has resulted in methodological and process support tools that facilitate collaborative scientific work and production of HTA information that can be shared across borders. The speakers discussed a number of important issues that could contribute to a permanent solution for sustainable HTA cooperation in Europe, including: - identifying ways in which the collaborative work produced at the European level can fit into national HTA and decision-making processes - creating processes to ensure that European cooperation effectively and efficiently contributes to HTA in participating countries - exploring opportunities and plans that can support synergy between European and national HTA processes - developing strategies to support regional cooperation between Member States and the EU Additional information on the ISPOR 19th Annual European Congress can be found here. Released presentations from the congress can be found here. Interested parties can follow news and developments from the conference on social media using the hashtag #ISPORVienna.

###

Related Stories

ISPOR Announces 2025-2026 Board of Directors

May 20, 2025

ISPOR announced the results of its recent elections and its 2025-2026 Board of Directors. The 2025-2026 board will assume office on July 1.

Value in Health Journal Spotlights "Whole Health" in Special Series

May 19, 2025

Value in Health, the official journal of ISPOR, announced the publication of a series of articles exploring the concept of "whole health"—a holistic approach to healthcare that extends beyond the traditional biomedical model to incorporate physical, mental, social, environmental, and spiritual dimensions of wellbeing.

Rethinking Medication Adherence: A Stakeholder Blueprint

May 12, 2025

Value in Health, the official journal of ISPOR—The Professional Society for Health Economics and Outcomes Research, announced today the publication of a report from its Medication Adherence and Persistence Special Interest Group that provides valuable insights into the perspectives of key stakeholders on interventions to improve medication adherence. The report, “Stakeholders’ Perspectives on Medication Adherence Enhancing Interventions: An ISPOR Report,” was published in the May 2025 issue of Value in Health.
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×